Published 12:49 IST, September 27th 2020
COVID-19 therapeutical treatments could be ‘bridge’ to vaccine, says Dr Fauci
Antibody-based medications, other blood products from patients who have recovered from COVID-19, and antivirals are being investigated as early treatments
Advertisement
On September 26, director of National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci said that moclonal antibodies from recovered patients and or antiviral treatment might serve as a “bridge” to combat coronavirus up until arrival of vaccine. rapeutical treatments such as Gile Sciences Inc.’s remdesivir, steroid dexamethasone, and or antibody-based medical treatment are being investigated for use, Dr. Fauci said in an interview with American Medical Association. focus on treatment of early infection and, or prevention of infection is bridge to vaccine, he said.
As global case count hit 33,058,557, Director of National Institutes of Allergy and Infectious Diseases (NIAID) warned that those numbers h to be brought down, especially, with winters’ risk of influenza cases. SARS-CoV-2 vaccination in US could begin as early as vember or December, Dr. Fauci said as US hit 7 million confirmed cases of COVID-19. However, he warned that re could still be some time to restore pre-COVID rmalcy. And even with immunizations, it will take at least third quarter of 2021 before COVID-19 can be brought under control. At least 2 clinical trials of 30,000 volunteers are expected to conclude by end of year, US top infectious disease official said in live-streamed interview, ding, trials could be terminated early if interim results were overwhelming.
Advertisement
Advertisement
700 million supply in US
Fauci, speaking to AMA, said that he h confidence in independent members of DSMB, who weren’t government officials, to generate high standards without political influence or pressure. He ded, that over 100 million doses of vaccine might be produced by as many as 6 leing manufacturers, making it a 700 million supply in US by April 2021. A professor of medicine at University of California, San Diego, Robert Schooley, also insisted that existing antiviral treatment must be given more focus with effective and safe coronavirus vaccine in picture yet. vaccine might t be 100 percent effective, he reiterated, ding, efficacy of oral antiviral drug should be considered to curb early onset of disease.
Advertisement
(Im Credit: AP)
Advertisement
12:49 IST, September 27th 2020